FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β-catenin signaling-dependent Runx2 expression

FASEB Journal

Volumn 22, Issue 11, 2008, Pages 3813-3822

  Hamidouche, Zahia ^a   Haÿ, Eric ^a   Vaudin, Pascal ^b   Charbord, Pierre ^a   Schüle, Roland ^c   Marie, Pierre J ^a,d   Fromigué, Olivia ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY OF FREIBURG   (Germany)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cell therapy; Osteogenesis; Signaling

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; COLLAGEN TYPE 1; DEXAMETHASONE; FHL2 PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; MESENCHYMAL STEM CELL; MINERALIZATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING;

MURINAE;

EID: 55549113911     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.08-106302     Document Type: Article

References (56)

1. Caplan, A. I. (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell Physiol. 213, 341-347
2. Phinney, D. G., and Prockop, D. J. (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair- current views. Stem Cells 25, 2896-2902
3. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147
4. Owen, M. (1988) Marrow stromal stem cells. J. Cell Sci. Suppl. 10, 63-76
5. Bianco, P., and Gehron Robey, P. (2000) Marrow stromal stem cells. J. Clin. Invest. 105, 1663-1668
6. Kimelman, N., Pelled, G., Gazit, Z., and Gazit, D. (2006) Applications of gene therapy and adult stem cells in bone bioengineering. Regen. Med. 1, 549-561
7. Kassem, M., and Abdallah, B. M. (2008) Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res. 331, 157-163
8. Marie, P. J., and Fromigue, O. (2006) Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen. Med. 1, 539-548
9. Karsenty, G., and Wagner, E. F. (2002) Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406
10. Lian, J. B., Stein, G. S., Stein, J. L., and van Wijnen, A. J. (1998) Transcriptional control of osteoblast differentiation. Biochem. Soc. Trans. 26, 14-21
11. Aubin, J. E. (1998) Bone stem cells. J. Cell Biochem. Suppl. 30-31, 73-82
12. Cheng, S. L., Yang, J. W., Rifas, L., Zhang, S. F., and Avioli, L. V. (1994) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134, 277-286
13. Bellows, C. G., Aubin, J. E., and Heersche, J. N. (1987) Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121, 1985-1992
14. Sher, L. B., Harrison, J. R., Adams, D. J., and Kream, B. E. (2006) Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif. Tissue Int. 79, 118-125
15. Sher, L. B., Woitge, H. W., Adams, D. J., Gronowicz, G. A., Krozowski, Z., Harrison, J. R., and Kream, B. E. (2004) Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 145, 922-929
16. Fromigue, O., Marie, P. J., and Lomri, A. (1997) Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine 9, 613-623
17. Glass, D. A., 2nd, and Karsenty, G. (2007) In vivo analysis of Wnt signaling in bone. Endocrinology 148, 2630-2634
18. Krishnan, V., Bryant, H. U., and Macdougald, O. A. (2006) Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116, 1202-1209
19. Baron, R., Rawadi, G., and Roman-Roman, S. (2006) Wnt signaling: a key regulator of bone mass. Curr. Top Dev. Biol. 76, 103-127
20. Bodine, P. V., and Komm, B. S. (2006) Wnt signaling and osteoblastogenesis. Rev. Endocr. Metab. Disord. 7, 33-39
21. Gordon, M. D., and Nusse, R. (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 281, 22429-22433
22. Boland, G. M., Perkins, G., Hall, D. J., and Tuan, R. S. (2004) Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J. Cell. Biochem. 93, 1210-1230
23. Etheridge, S. L., Spencer, G. J., Heath, D. J., and Genever, P. G. (2004) Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22, 849-860
24. Baksh, D., and Tuan, R. S. (2007) Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J. Cell Physiol. 212, 817-826
25. Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., and MacDougald, O. A. (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. U. S. A. 102, 3324-3329
26. Si, W., Kang, Q., Luu, H. H., Park, J. K., Luo, Q., Song, W. X., Jiang, W., Luo, X., Li, X., Yin, H., Montag, A. G., Haydon, R. C., and He, T. C. (2006) CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol. Cell. Biol. 26, 2955-2964
27. Zhou, H., Mak, W., Zheng, Y., Dunstan, C. R., and Seibel, M. J. (2008) Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J. Biol. Chem. 283, 1936-1945
28. De Boer, J., Siddappa, R., Gaspar, C., van Apeldoorn, A., Fodde, R., and van Blitterswijk, C. (2004) Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34, 818-826
29. Ohnaka, K., Taniguchi, H., Kawate, H., Nawata, H., and Takayanagi, R. (2004) Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem. Biophys. Res. Commun. 318, 259-264
30. Wang, F. S., Lin, C. L., Chen, Y. J., Wang, C. J., Yang, K. D., Huang, Y. T., Sun, Y. C., and Huang, H. C. (2005) Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology 146, 2415-2423
31. Smith, E., and Frenkel, B. (2005) Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. J. Biol. Chem. 280, 2388-2394
32. Smith, E., Redman, R. A., Logg, C. R., Coetzee, G. A., Kasahara, N., and Frenkel, B. (2000) Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J. Biol. Chem. 275, 19992-20001
33. Eijken, M., Meijer, I. M., Westbroek, I., Koedam, M., Chiba, H., Uitterlinden, A. G., Pols, H. A., and van Leeuwen, J. P. (2008) Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner. J. Cell. Biochem. 104, 568-579
34. Genini, M., Schwalbe, P., Scholl, F. A., Remppis, A., Mattei, M. G., and Schafer, B. W. (1997) Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol. 16, 433-442
35. Johannessen, M., Moller, S., Hansen, T., Moens, U., and Van Ghelue, M. (2006) The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell. Mol. Life Sci. 63, 268-284
36. Martin, B., Schneider, R., Janetzky, S., Waibler, Z., Pandur, P., Kuhl, M., Behrens, J., von der Mark, K., Starzinski-Powitz, A., and Wixler, V. (2002) The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J. Cell Biol. 159, 113-122
37. Wei, Y., Renard, C. A., Labalette, C., Wu, Y., Levy, L., Neuveut, C., Prieur, X., Flajolet, M., Prigent, S., and Buendia, M. A. (2003) Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J. Biol. Chem. 278, 5188-5194
38. Gunther, T., Poli, C., Muller, J. M., Catala-Lehnen, P., Schinke, T., Yin, N., Vomstein, S., Amling, M., and Schule, R. (2005) Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts. EMBO J. 24, 3049-3056
39. Govoni, K. E., Baylink, D. J., Chen, J., and Mohan, S. (2006) Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice. Calcif. Tissue Int. 79, 112-117
40. Lai, C. F., Bai, S., Uthgenannt, B. A., Halstead, L. R., McLoughlin, P., Schafer, B. W., Chu, P. H., Chen, J., Otey, C. A., Cao, X., and Cheng, S. L. (2006) Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation. J. Bone Miner. Res. 21, 17-28
41. Dennis, J. E., Merriam, A., Awadallah, A., Yoo, J. U., Johnstone, B., and Caplan, A. I. (1999) A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J. Bone Miner. Res. 14, 700-709
42. Delorme, B., and Charbord, P. (2007) Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol. Med. 140, 67-81
43. Shibamoto, S., Higano, K., Takada, R., Ito, F., Takeichi, M., and Takada, S. (1998) Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells 3, 659-670
44. Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman Roman, S., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., Mollat, P., Niehrs, C., Baron, R., and Rawadi, G. (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J. Bone Miner. Res. 21, 934-945
45. Lee, B., Thirunavukkarasu, K., Zhou, L., Pastore, L., Baldini, A., Hecht, J., Geoffroy, V., Ducy, P., and Karsenty, G. (1997) Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16, 307-310
46. Fromigue, O., Hay, E., Modrowski, D., Bouvet, S., Jacquel, A., Auberger, P., and Marie, P. J. (2006) RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ. 13, 1845-1856
47. Luppen, C. A., Smith, E., Spevak, L., Boskey, A. L., and Frenkel, B. (2003) Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J. Bone Miner. Res. 18, 1186-1197
48. Fromigue, O., Lagneaux, L., and Body, J. J. (2000) Bisphosphonates induce breast cancer cell death in vitro. J. Bone Miner. Res. 15, 2211-2221
49. Gaur, T., Lengner, C. J., Hovhannisyan, H., Bhat, R. A., Bodine, P. V., Komm, B. S., Javed, A., van Wijnen, A. J., Stein, J. L., Stein, G. S., and Lian, J. B. (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280, 33132-33140
50. Karsenty, G. (2000) Role of Cbfa1 in osteoblast differentiation and function. Semin. Cell Dev. Biol. 11, 343-346
51. Komori, T. (2008) Regulation of bone development and maintenance by Runx2. Front. Biosci. 13, 898-903
52. Lian, J. B., Javed, A., Zaidi, S. K., Lengner, C., Montecino, M., van Wijnen, A. J., Stein, J. L., and Stein, G. S. (2004) Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit. Rev. Eukaryot. Gene Expr. 14, 1-41
53. Morlon, A., and Sassone-Corsi, P. (2003) The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc. Natl. Acad. Sci. U. S. A. 100, 3977-3982
54. McLoughlin, P., Ehler, E., Carlile, G., Licht, J. D., and Schafer, B. W. (2002) The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein. J. Biol. Chem. 277, 37045-37053
55. Lian, J. B., and Stein, G. S. (2003) The temporal and spatial subnuclear organization of skeletal gene regulatory machinery: integrating multiple levels of transcriptional control. Calcif. Tissue Int. 72, 631-637
56. Wagner, E. F., and Eferl, R. (2005) Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208, 126-140